AMS
American Shared Hospital Services2.1300
-0.0100-0.47%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
13.94MP/E (TTM)
-Basic EPS (TTM)
-0.35Dividend Yield
0%Recent Filings
8-K
8-K
10-Q
Q2 FY2025 results
American Shared Hospital Services posted Q2 revenue of $7.1M, up slightly y/y but flat q/q amid leasing declines offset by direct patient services growth from the Rhode Island centers acquired in May 2024 for $2.85M cash, recognizing a bargain purchase gain last year. Gross margin shrank to 23.1% from 35.0% y/y, pressured by higher operating costs in the new facilities, while operating loss widened to $0.5M from near breakeven; net loss hit $0.3M or $0.04 per diluted share on 6.6M shares, versus $3.6M profit last year driven by the acquisition gain. YTD revenue climbed 7.5% to $13.2M, but net loss deepened to $0.9M or $0.14 per share from $3.7M profit, with EPS aligning to weighted shares and no anti-dilution. Cash held steady at $11.1M with $2.1M operating cash flow, supporting $19.1M debt at SOFR+3% (7.49%); free cash flow not disclosed in the 10-Q. Procedure volumes dipped across Gamma Knife and PBRT segments due to contract expirations and cycles. Debt covenants slipped temporarily at quarter-end but recovered by July. Competition from alternative therapies remains a key risk.
8-K
Q2 revenue edges up 0.2%
American Shared Hospital Services reported Q2 2025 revenue of $7.1 million, up 0.2% year-over-year but down from last year's bargain purchase gain that boosted profits. Direct patient services surged 11% to $3.5 million, fueled by Rhode Island centers and Puebla, Mexico launch, while leasing dipped 8% due to expired Gamma Knife contracts and cyclical proton therapy dips. Expansion shines. Net loss hit $0.3 million, yet Adjusted EBITDA held at $1.7 million amid rising volumes.
8-K
Shareholders approve board, pay
American Shared Hospital Services held its annual shareholder meeting on June 26, 2025, with 83.46% quorum. Shareholders elected Daniel G. Kelly, Jr., Kathleen Miles, Raymond C. Stachowiak, and Vicki L. Wilson to the board. They approved executive compensation, annual advisory votes on pay, and ratified Baker Tilly US, LLP as auditors. Strong support signals board stability.
ACHC
Acadia Healthcare Company, Inc.
14.43+0.21
AIRS
AirSculpt Technologies, Inc.
2.57-0.06
AMN
AMN Healthcare Services Inc
15.82-0.17
AONC
American Oncology Network, Inc.
11.12+0.00
ARAY
Accuray Incorporated
1.02-0.03
ARDT
Ardent Health, Inc.
8.93+0.03
CCM
Concord Medical Services Holdin
4.33-0.22
CYH
Community Health Systems, Inc.
3.25+0.03
NUTX
Nutex Health Inc.
171.72-4.06
SRXH
SRX Health Solutions, Inc.
0.38+0.07